AFME Stock Overview
Develops minimally invasive medical devices in the field of urology and structural heart in France. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 2 more risks
My Notes
Capture your thoughts, links and company narrative
Affluent Medical SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.43 |
| 52 Week High | €2.26 |
| 52 Week Low | €1.19 |
| Beta | 0.59 |
| 1 Month Change | -13.86% |
| 3 Month Change | -22.91% |
| 1 Year Change | -37.55% |
| 3 Year Change | -74.74% |
| 5 Year Change | n/a |
| Change since IPO | -82.13% |
Recent News & Updates
Recent updates
Shareholder Returns
| AFME | FR Medical Equipment | FR Market | |
|---|---|---|---|
| 7D | -0.3% | 0.003% | -1.7% |
| 1Y | -37.6% | 23.6% | -4.8% |
Return vs Industry: AFME underperformed the French Medical Equipment industry which returned 23.6% over the past year.
Return vs Market: AFME underperformed the French Market which returned -4.8% over the past year.
Price Volatility
| AFME volatility | |
|---|---|
| AFME Average Weekly Movement | 10.0% |
| Medical Equipment Industry Average Movement | 6.7% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: AFME's share price has been volatile over the past 3 months compared to the French market.
Volatility Over Time: AFME's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of French stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 66 | Sebastien Ladet | www.affluentmedical.com |
Affluent Medical SA develops minimally invasive medical devices in the field of urology and structural heart in France. It offers Artus, an implantable electro-mechanical artificial sphincter that targets moderate to severe urinary incontinence; and Kalios and Epygon implants for the treatment of mitral insufficiency, as well as Kardiozis technology for treating abdominal aortic aneurysm. The company was founded in 2011 and is based in Aix-en-Provence, France.
Affluent Medical SA Fundamentals Summary
| AFME fundamental statistics | |
|---|---|
| Market cap | €56.25m |
| Earnings (TTM) | -€17.04m |
| Revenue (TTM) | €1.30m |
43.4x
P/S Ratio-3.3x
P/E RatioIs AFME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFME income statement (TTM) | |
|---|---|
| Revenue | €1.30m |
| Cost of Revenue | €2.35m |
| Gross Profit | -€1.05m |
| Other Expenses | €15.99m |
| Earnings | -€17.04m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.43 |
| Gross Margin | -81.31% |
| Net Profit Margin | -1,315.91% |
| Debt/Equity Ratio | 63.5% |
How did AFME perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 03:57 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Affluent Medical SA is covered by 2 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Clément Bassat | Portzamparc BNP Paribas |
| Corentin Marty | TPICAP Midcap |